On ECHEMI
Home > Drugs > Shock
Shock
Shock refers to a systemic critical pathological process in which, under the influence of various strong pathogenic factors, the body's circulatory function declines sharply, the microcirculatory perfusion of tissues and organs is seriously insufficient, and the function and metabolism of important vital organs are seriously impaired. It is a common complication in serious diseases in various clinical departments. The common feature of shock is insufficient effective circulation. Although the blood perfusion of tissues and cells is compensated, it is still severely restricted, which causes poor blood perfusion of tissues and organs throughout the body, leading to a series of pathological and physiological changes such as tissue hypoxia, microcirculatory stasis, organ dysfunction and abnormal cell metabolic function. The pathogenesis of shock generally develops from compensatory hypotension (reduced tissue perfusion) to microcirculatory failure, and finally leads to cell membrane damage and cell death.
  • Site of disease:

    whole body
  • Infectious :

    Not contagious
  • Frequent population:

    All people, mostly elderly people
  • Related symptoms:

    Blood pressure drops pale complexion cold and clammy skin weak pulse that can't even be felt clearly less urine
Related Drugs
Shenmai Injection
Manufacturer:

Chiatai Qingchunbao Pharmaceutical Co., Ltd.

Shenmai Injection
Manufacturer:

Sichuan Chuanda West China Pharmaceutical Co., Ltd.

Shenmai Injection
Manufacturer:

Chiatai Qingchunbao Pharmaceutical Co., Ltd.

Shenmai Injection
Manufacturer:

Yunnan Phyto Pharmaceutical Co., Ltd.

Shenmai Injection
Manufacturer:

Dali Pharmaceutical Co., Ltd.

Shenmai Injection
Manufacturer:

Dali Pharmaceutical Co., Ltd.

Human serum albumin
Indication: 1. Shock caused by blood loss, trauma, and burns. 2. Increased intracranial pressure caused by cerebral edema and injury. 3. Edema or ascites caused by cirrhosis and kidney disease. 4. Prevention and treatment of hypoproteinemia. 5. Neonatal hyperbilirubinemia. 6. Used in cardiopulmonary bypass, auxiliary treatment of burns, auxiliary treatment of hemodialysis, and adult respiratory distress syndrome.
LMD IN DEXTROSE- dextran 40_injection, solution
Indication: LMD (dextran 40) is indicated for use in the adjunctive treatment of shock or impending shock due to hemorrhage, burns, surgery or other trauma. It is not indicated as a replacement for whole blood or blood components if they are available. It should not replace other forms of therapy known to be of value in the treatment of shock. LMD is also indicated for use as a priming fluid, either as a sole prime or as an additive, in pump oxygenators during extracorporeal circulation. LMD is also indicated for use in prophylaxis of venous thrombosis and pulmonary embolism in patients undergoing procedures known to be associated with a high incidence of thromboembolic complications, such as hip surgery.
Manufacturer:

LMD IN SODIUM CHLORIDE- dextran 40_injection, solution

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.